Here are 10 facts:
1. The target price is set at $521.11.
2. Six analysts have granted the stock a “hold” recommendation and five analysts have given the stock a “buy” rating.
3. Analysts at Barclays set an “overweight” rating and a $575.00 price target on the stock.
4. Alan J. Levy, director of Intuitive Surgical, sold 417 shares of the stock in a transaction occurring Tuesday, June 9.
5. The transaction totaled $206,585.97 with the stock selling at an average price of $494.41.
6. Intuitive Surgical stock has a 50-day moving average of $495 and a 200-day moving average of $508.
7. The company’s market cap is $18.32 billion and a price-to-earnings ratio of 39.38.
8. Last quarter, Intuitive Surgical reported $3.57 earnings per share.
9. Revenue for last quarter reached $532.10 million compared to the consensus estimate of $535.10 million.
10. Intuitive Surgical revenue for the quarter was a 14.5 percent increase on a year-over-year basis.
For more news on devices:
Zimmer, Medtronic, Amendia & more — 27 key notes
US, Spain hospitals purchase robotic spine systems — 5 key notes
8 trends in the global spinal non-fusion market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
